Exact Sciences Corporation (EXAS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: May 28, 2015
Pages: 31
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E2D048B5F63EN
Leaflet:

Download PDF Leaflet

Exact Sciences Corporation (EXAS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Exact Sciences Corporation (Exact) is a molecular diagnostics company. It focuses on the early detection and prevention of colorectal cancer. The company has developed Cologuard test, a non-invasive stool-based deoxyribonucleic acid (sDNA) screening technology product to detect DNA markers. It is used to detect presence of colorectal pre-cancer and cancer. Exact’s Cologuard test also includes protein marker to detect blood in the stool, utilizing an antibody based fecal immunochemical test (FIT). It has collaboration with companies such as Mayo Clinic, Genzyme Corporation, Hologic, Inc., MDx Health and Ironwood Pharmaceuticals to offer licenses and develop new products. The company operates a CLIA certified laboratory facility to process Cologuard tests. It also operates through its subsidiary in the UK. EXACT is headquartered in Madinson, Wisconsin, the US

The company intends to maximize its patent portfolio against third parties to cover the methods to detect and eradicate colorectal cancer. To this end it has received FDA approval for its Cologuard for use as the first and only sDNA noninvasive colorectal cancer screening test.

Exact Sciences Corporation (EXAS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Exact Sciences Corporation, Medical Devices Deals, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deal Details
Licensing Agreements
Genzyme Amends Licensing Agreement With Exact Sciences
Equity Offering
Exact Sciences Completes Public Offering Of Shares For US$146.6 Million
Exact Sciences Completes Public Offering Of Shares For US$78 Million
Exact Sciences Completes Public Offering of Common Stock For US$62 Million
Exact Sciences Completes Underwritten Public Offering Of US$69 Million
Exact Sciences Completes Underwritten Public Offering Of Common Stock For US$18.9 Million
EXACT Sciences Completes Private Placement Of US$8.2 Million
EXACT Sciences Completes Private Placement Of US$6 Million
Acquisition
SEQUENOM Terminates Its Offer To Acquire EXACT Sciences
Genzyme Acquires Minority Stake In EXACT Sciences
Exact Sciences Corporation - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Exact Sciences Corporation, Pharmaceuticals & Healthcare, Key Facts, 2014
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Exact Sciences Corporation, Deals By Therapy Area, 2009 to YTD 2015
Exact Sciences Corporation, Medical Devices Deals, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Genzyme Amends Licensing Agreement With Exact Sciences
Exact Sciences Completes Public Offering Of Shares For US$146.6 Million
Exact Sciences Completes Public Offering Of Shares For US$78 Million
Exact Sciences Completes Public Offering of Common Stock For US$62 Million
Exact Sciences Completes Underwritten Public Offering Of US$69 Million
Exact Sciences Completes Underwritten Public Offering Of Common Stock For US$18.9 Million
EXACT Sciences Completes Private Placement Of US$8.2 Million
EXACT Sciences Completes Private Placement Of US$6 Million
SEQUENOM Terminates Its Offer To Acquire EXACT Sciences
Genzyme Acquires Minority Stake In EXACT Sciences
Exact Sciences Corporation, Key Competitors
Exact Sciences Corporation, Key Employees
Exact Sciences Corporation, Subsidiaries

LIST OF FIGURES

Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Exact Sciences Corporation, Medical Devices Deals, 2009 to YTD 2015
Skip to top


Ask Your Question

Exact Sciences Corporation (EXAS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: